|
Rockland Immunochemicals
anti collagen type ii rabbit antibody Anti Collagen Type Ii Rabbit Antibody, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti collagen type ii rabbit antibody/product/Rockland Immunochemicals Average 96 stars, based on 1 article reviews
anti collagen type ii rabbit antibody - by Bioz Stars,
2026-03
96/100 stars
|
Buy from Supplier |
|
Addgene inc
herpes simplex virus thymidine kinase allele Herpes Simplex Virus Thymidine Kinase Allele, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/herpes simplex virus thymidine kinase allele/product/Addgene inc Average 93 stars, based on 1 article reviews
herpes simplex virus thymidine kinase allele - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Bioworld Antibodies
primary antibodies against col2 ![]() Primary Antibodies Against Col2, supplied by Bioworld Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/primary antibodies against col2/product/Bioworld Antibodies Average 90 stars, based on 1 article reviews
primary antibodies against col2 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Artialis Inc
degradation [coll2-1] ![]() Degradation [Coll2 1], supplied by Artialis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/degradation [coll2-1]/product/Artialis Inc Average 90 stars, based on 1 article reviews
degradation [coll2-1] - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Merck KGaA
collagen type ii 6b3 antibody ![]() Collagen Type Ii 6b3 Antibody, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/collagen type ii 6b3 antibody/product/Merck KGaA Average 90 stars, based on 1 article reviews
collagen type ii 6b3 antibody - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Cosmo Bio USA
type ii collagen (col2) antibody ![]() Type Ii Collagen (Col2) Antibody, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/type ii collagen (col2) antibody/product/Cosmo Bio USA Average 90 stars, based on 1 article reviews
type ii collagen (col2) antibody - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Jackson Laboratory
col2.3creer ![]() Col2.3creer, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/col2.3creer/product/Jackson Laboratory Average 90 stars, based on 1 article reviews
col2.3creer - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Qiagen
col2a1-promoter luciferase reporter plasmid ![]() Col2a1 Promoter Luciferase Reporter Plasmid, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/col2a1-promoter luciferase reporter plasmid/product/Qiagen Average 90 stars, based on 1 article reviews
col2a1-promoter luciferase reporter plasmid - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
IBEX Technologies
antibodies against c1,2c (col2 3⁄4 cshort) neoepitope ![]() Antibodies Against C1,2c (Col2 3⁄4 Cshort) Neoepitope, supplied by IBEX Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/antibodies against c1,2c (col2 3⁄4 cshort) neoepitope/product/IBEX Technologies Average 90 stars, based on 1 article reviews
antibodies against c1,2c (col2 3⁄4 cshort) neoepitope - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
GenScript corporation
col2 peptides ![]() Col2 Peptides, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/col2 peptides/product/GenScript corporation Average 90 stars, based on 1 article reviews
col2 peptides - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Coriell Institute for Medical Research
col2-pathy hdfs ![]() Col2 Pathy Hdfs, supplied by Coriell Institute for Medical Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/col2-pathy hdfs/product/Coriell Institute for Medical Research Average 90 stars, based on 1 article reviews
col2-pathy hdfs - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Genetica Inc
col2-3/4cshort ![]() Col2 3/4cshort, supplied by Genetica Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/col2-3/4cshort/product/Genetica Inc Average 90 stars, based on 1 article reviews
col2-3/4cshort - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Arthritis Research & Therapy
Article Title: Ketogenic diet ameliorates inflammation by inhibiting the NLRP3 inflammasome in osteoarthritis
doi: 10.1186/s13075-022-02802-0
Figure Lengend Snippet: Evaluation of cartilage degeneration in the knee joint. A Expression of MMP13 and COL2 was detected using immunohistochemistry. Scale bar, 20 μm. B , C Quantitative analysis of the expression of MMP13 and COL2 in immunohistochemical results. n = 3 per group, with a total of 9 animals used. # P < 0.05 versus the sham group, * P < 0.05 versus the SD group
Article Snippet: The specimens were incubated with primary antibodies against NLRP3 (1:100, Abcam, MA, USA), ASC (1:100, Abcam, MA, USA), Caspase-1 p20 (1:100, Bioworld Technology, MN, USA), IL-1β (1:100, Bioworld Technology, MN, USA), IL-18 (1:100, Bioworld Technology, MN, USA), MMP13 (1:100, Abcam, MA, USA), and
Techniques: Expressing, Immunohistochemistry, Immunohistochemical staining
Journal: Scientific Reports
Article Title: Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus -conditioned media
doi: 10.1038/s41598-024-68404-9
Figure Lengend Snippet: Effects of TLR2-blockade on expression levels of chondrocyte development and cartilage degradation-related genes in PG peptide-stimulated chondrocytes. Knee OA chondrocytes (N = 10) were treated with 50 ng/ml of IFNγ and 10 µg/ml of PG peptides (p16-31, p263-280 or p2379-2394), the aggrecan 32-mer peptide or Col2 peptide in the presence of 20 ng/ml of anti-TLR2 antibodies and expression levels of chondrocyte development and cartilage degradation-related genes were determined by quantitative realtime PCR. Comparison of expression levels of chondrocyte differentiation and development (HOXA11, SOX5 and RUNX2) ( A ), cartilagenous matrix (COL2A1) ( B ), and cartilage degradation (IL-6) ( C ) -related genes from chondrocytes stimulated with IFNγ and PG peptides, aggrecan 32-mer peptide and Col2 peptide with and without anti-TLR2 treated chondrocytes were normalized to GAPDH and interpreted as relative expression levels (fold change) (Y-axis). Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).
Article Snippet: Isolated chondrocytes were cultured in a 48-well plate (1 × 10 5 cells/well) and stimulated with 50 ng/ml IFNγ (R&D System) with either 10 μg/ml p16-31, p263-280, p2379-2394, 32-mer or
Techniques: Expressing, Comparison
Journal: Scientific Reports
Article Title: Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus -conditioned media
doi: 10.1038/s41598-024-68404-9
Figure Lengend Snippet: Effects of TLR2 blockade on cartilage-degrading enzyme production in PG peptide-stimulated chondrocytes. Knee OA chondrocytes (N = 10) were treated with 50 ng/ml of IFNγ and 10 µg/ml of PG peptides (p16-31, p263-280 or p2379-2394), the aggrecan 32-mer peptide or Col2 peptide in the presence of 20 ng/ml of anti-TLR2 antibodies. Cartilage degrading- enzymes (MMP-1, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5) and IL-6 production were determined by ELISA. ( A ) Bar graphs showing comparison of MMP-1, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5 production from IFNγ and PG peptide, aggrecan 32-mer peptide and Col2 peptide stimulation with ( +) and without (-) anti-TLR2 antibodies. Y-axis represents cartilage-degrading enzyme concentrations (pg/ml). ( B ) Bar graphs showing percentage of inhibition of MMP-1, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5 production after TLR2 blockade in each stimulation condition. ( C ) Bar graph showing comparison of IL-6 production from IFNγ and PG peptide stimulation with ( +) and without (-) anti-TLR2 antibody. Y-axis represents IL-6 concentration (pg/ml). ( D ) Bar graph showing the percentage of inhibition of IL-6 production after TLR2 blocking in IFNγ and PG peptide-stimulated chondrocytes. Data was shown as mean ± SEM and significant difference of cartilage degrading factor production was calculated by two-way ANOVA with bonferroni post hoc test, while significant difference of percentage of inhibition was calculated by one-way ANOVA with post-hoc Turky HSD (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).
Article Snippet: Isolated chondrocytes were cultured in a 48-well plate (1 × 10 5 cells/well) and stimulated with 50 ng/ml IFNγ (R&D System) with either 10 μg/ml p16-31, p263-280, p2379-2394, 32-mer or
Techniques: Enzyme-linked Immunosorbent Assay, Comparison, Inhibition, Concentration Assay, Blocking Assay
Journal: Scientific Reports
Article Title: Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus -conditioned media
doi: 10.1038/s41598-024-68404-9
Figure Lengend Snippet: Inhibition effect of Lactobacillus- conditioned medium on cartilage degraded mediators released from chondrocytes after IFNγ with PG peptides treatment. Chondrocytes isolated from OA patients (N = 4) were treated with 10% of Lactobacillus -conditioned medium (LCM), L. gasseri- L10 (LG-L10), L. rhamnosus-L34 (LR-L34), L. casei -L39 (LC-L39), L. salivarius -B60 (LS-B60) and L. plantarum -XB7 (LP-XB7) before stimulating with IFNγ and either PG peptides (p16-31, p263-280 and p2379-2394) or control peptides (32-mer and Col2). The cultured medium was collected for cartilage degraded mediators measurement by ELISA. ( A ) Comparison of MMP-1, MMP-9, MMP-13, ADAMTS-4, ADAMTS-5 and IL-6 production from IFNγ and PG peptides stimulated chondrocytes between LCM-treated and untreated conditions ( B ) Bar graphs show the MMP-1 and MMP-13 production in 10% LCM-treated chondrocytes (without IFNγ and PG peptides stimulation) compared with that of chondrocytes treated with 10% of heated LCM. ( C ) Bar graphs show the MMP-1 and MMP-13 production in 10% LCM-treated chondrocytes (without IFNγ and PG peptides stimulation) compared with that of chondrocytes treated with 10% of proteinase K-treated LCM. Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with Bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).
Article Snippet: Isolated chondrocytes were cultured in a 48-well plate (1 × 10 5 cells/well) and stimulated with 50 ng/ml IFNγ (R&D System) with either 10 μg/ml p16-31, p263-280, p2379-2394, 32-mer or
Techniques: Inhibition, Isolation, Control, Cell Culture, Enzyme-linked Immunosorbent Assay, Comparison
Journal: Scientific Reports
Article Title: Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus -conditioned media
doi: 10.1038/s41598-024-68404-9
Figure Lengend Snippet: Effects of TLR2 blockade and Lactobacillus- conditioned media treatment on intracellular signaling activation in PG peptide-stimulated chondrocytes. Chondrocytes isolated from OA patients (N = 5) were treated with 20 μg/ml of anti-TLR2 antibodies or 10% of LCM, L. salivarius -B60 for 1 h before stimulating with IFNγ and PG peptides (p16-31, p263-280 and p2379-2394) or control peptides (32-mer and Col2 peptides). Intracellular phosphorylated proteins; p-STAT3, p-IkBα, p-ERK1/2, p-p38 and p-MAPK9 (JNK2) were determined by flow cytometry. ( A ) Bar graph showing the fold change of mean fluorescent intensity of phosphorylated proteins of stimulated chondrocyte which was divided by that of unstimulated chondrocytes. Statistical significance was calculated by one-way ANOVA with post-hoc Turky HSD. ( B ) Comparison of mean fluorescence intensity (MFI) of phosphorylated protein expression after stimulating with IFNγ and PG peptides between no blocking and anti-TLR2 antibody treatment (upper panel) or between no blocking and L. salivarius -B60 LCM treatment in each individual. Statistical significance was calculated by paired-T test. ( C ) Bar graphs showing the comparison of percentage of phosphorylated protein- expressing chondrocytes in no blocking, anti-TLR2 antibody treatment and L. salivarius -B60 LCM treatment conditions after stimulation with IFNγ and PG peptides or control peptides. Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with Bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).
Article Snippet: Isolated chondrocytes were cultured in a 48-well plate (1 × 10 5 cells/well) and stimulated with 50 ng/ml IFNγ (R&D System) with either 10 μg/ml p16-31, p263-280, p2379-2394, 32-mer or
Techniques: Activation Assay, Isolation, Control, Flow Cytometry, Comparison, Fluorescence, Expressing, Blocking Assay